advancing innovation to save lives

GHTC director profiled in Impact Magazine

GHTC Director Jamie Bay Nishi was profiled in an article by Impact Magazine, covering challenges facing global health research and development (R&D) and the coalition's efforts to better inform policy makers.
View

Return on innovation

A new report from GHTC examines the impact of US government investment in global health R&D at home and abroad, from delivering lifesaving tools for the world’s most vulnerable people to generating economic and security returns for the United States.
 
Learn More

Jhpiego

Jhpiego (pronounced "ja-pie-go") is an international, non-profit health organization affiliated with Johns Hopkins University. For 42 years, Jhpiego has empowered front-line health workers by designing and implementing effective, low-cost, hands-on solutions to strengthen the delivery of health care services for women and their families.
Learn More

GHTC works to save and improve lives by encouraging the research and development of essential health technologies. We are a coalition of more than 25 nonprofit organizations advancing policies to accelerate the creation of new drugs, vaccines, diagnostics, and other health tools that bring healthy lives within reach for all people.

Why we're needed

Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity in reach for all people.

Learn more
PATH/Matthew Dakin
Avvenire covers launch of GHTC report quantifying impact of US global health R&D funding

Italian newspaper Avvenire covered the launch of GHTC's report—Return on innovation: Why global health R&D is a smart investment for the United States—which explore how US government investments in global health R&D are delivering economic and security returns for America, as well as advancing the development of lifesaving technologies.

View
PATH/Gave Bienczycki
CIDRAP covers GHTC report detailing economic impact of global health research

The Center for Infectious Disease Research and Policy (CIDRAP) at the University of Michigan covered GHTC's report Return on innovation: Why global health R&D is a smart investment for America, which details the economic impact of US government spending on global health R&D.

View
View All News & Events

Member Event

PATH/Eric Becker
Results International Conference 2017
Results
Learn More

Community Event

PATH/Matthew Dakin
9th IAS Conference on HIV Science
IAS
Learn More
View All Events
PATH/Gabe Bienczycki
The goal of an AIDS-free generation: The time to invest in science is now

Mitchell Warren, the executive director of AVAC and a founding member of GHTC, wrote the following op-ed in reaction to Secretary of State Hillary Clinton’s speech at the National Institutes of Health and her announcement to prioritize achieving an AIDS-free generation. This op-ed originally appeared in The Hill’s “Congress Blog” this week.

AVAC
Read More
New collaboration to Bolster the fight against TB

The most recent WHO TB Control report noted that rates of TB declined this past year for the first time in decades. However, even with such progress, TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease.

TB Alliance
Read More
View Breakthroughs Blog

Our members work to improve health worldwide